{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:43:31Z","timestamp":1777923811589,"version":"3.51.4"},"reference-count":38,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Nucleic Acid Therapeutics"],"published-print":{"date-parts":[[2012,4]]},"abstract":"<jats:p>DNAzymes of the 10-23 family represent an important class of antisense molecules with implications for therapeutic treatment of diseases. These molecules are single-stranded oligodeoxynucleotides combining the high specificity of oligonucleotide base pairing with an inherent RNA-cleaving enzymatic activity. However, like other oligonucleotide-based molecules these substances might exert so-called off-target effects, which have not been investigated so far for this molecule class. Therefore, the present study investigates putative off-target effects of DNAzymes on innate immune mechanisms using GATA-3-specific DNAzymes that have recently been developed as novel therapeutic approach for the treatment of allergic diseases including allergic asthma. The conserved catalytic domain of 10-23 DNAzymes contains a CpG motif that may stimulate innate immune cells via Toll-like receptor 9 (TLR-9). Therefore, potential TLR-9-mediated as well as TLR-9 independent cell activation was investigated using TLR-9-transfected HEK293 cells, macrophage cell lines and primary innate immune cells. Furthermore, putative effects of GATA-3-specific DNAzymes on the activation of neutrophil granulocytes and degranulation of mast cells\/basophils were analyzed. In summary, no innate immune cell-stimulating activities of the tested DNAzymes were observed in any of the systems. Consequently, use of GATA-3-specific DNAzymes may represent a novel and highly specific approach for the treatment of allergic diseases.<\/jats:p>","DOI":"10.1089\/nat.2011.0294","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T22:52:51Z","timestamp":1533855171000},"page":"117-126","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Absence of Unspecific Innate Immune Cell Activation by GATA-3-Specific DNAzymes"],"prefix":"10.1177","volume":"22","author":[{"given":"Tanja","family":"Dicke","sequence":"first","affiliation":[{"name":"GmbH & Co. KG","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Pali-Sch\u00f6ll","sequence":"additional","affiliation":[{"name":"University of Vienna","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Philipps University of Marburg","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Bauer","sequence":"additional","affiliation":[{"name":"Philipps University of Marburg","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Renz","sequence":"additional","affiliation":[{"name":"Philipps University of Marburg","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Garn","sequence":"additional","affiliation":[{"name":"GmbH & Co. KG","place":["Germany"]},{"name":"Philipps University of Marburg","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,4]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.161293498"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8029-y"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1089\/oli.2009.0213"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.010909.105547"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-5521(94)90014-0"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-5521(95)90028-4"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1458"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1702"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(88)90050-1"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38294"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1089\/oli.1.1998.8.vii"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1089\/oli.2009.0219"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/newbio244073b0"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1225"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2008.12.007"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-36-1-59"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/11536140-000000000-00000"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050631"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2690"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00777.x"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1112"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature06765"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2004.06.028"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/257393a0"},{"key":"e_1_3_3_26_1","first-page":"513","article-title":"Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible? Drug Discov","volume":"13","author":"RAYBURN E.R.","year":"2008","unstructured":"RAYBURN E.R., , ZHANG R. 2008. Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible? Drug Discov. Today, 13:513\u2013521.","journal-title":"Today"},{"key":"e_1_3_3_27_1","first-page":"210","article-title":"Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model","volume":"9","author":"REICH S.J.","year":"2003","unstructured":"REICH S.J., , FOSNOT J., , KUROKI A., , TANG W., , YANG X., , MAGUIRE A.M., , BENNETT J., , TOLENTINO M.J. 2003. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol. Vis., 9:210\u2013216.","journal-title":"Mol. Vis."},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2008.131"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1089\/oli.2009.0180"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.122156"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.9.4262"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.06-7223com"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.12.1175"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2008.03191.x"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910170504"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature06013"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052191"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.1.280"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7310002"}],"container-title":["Nucleic Acid Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/nat.2011.0294","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/nat.2011.0294","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/nat.2011.0294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:57:32Z","timestamp":1777669052000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/nat.2011.0294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.1089\/nat.2011.0294"],"URL":"https:\/\/doi.org\/10.1089\/nat.2011.0294","relation":{},"ISSN":["2159-3337","2159-3345"],"issn-type":[{"value":"2159-3337","type":"print"},{"value":"2159-3345","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}